Janicic N, Pausova Z, Cole D E, Hendy G N
Department of Medicine, McGill University, Montreal, Canada.
Am J Hum Genet. 1995 Apr;56(4):880-6.
Missense mutations in the calcium-sensing receptor (CaR) gene have previously been identified in patients with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT). We studied family members of a Nova Scotian deme expressing both FHH and NSHPT and found, by PCR amplification of CaR gene exons, that FHH individuals were heterozygous and NSHPT individuals were homozygous for an abnormally large exon 7. This is due to an insertion at codon 877 of an Alu-repetitive element of the predicted-variant/human-specific-1 subfamily. It is in the opposite orientation to the CaR gene and contains an exceptionally long poly(A) tract. Stop signals are introduced in all reading frames within the Alu sequence, leading to a predicted shortened mutant CaR protein. The loss of the majority of the CaR carboxyl-terminal intracellular domain would dramatically impair its signal transduction capability. Identification of the specific mutation responsible for the FHH/NSHPT phenotype in this community will allow rapid testing of at-risk individuals.
钙敏感受体(CaR)基因的错义突变先前已在家族性低钙血症性高钙血症(FHH)和新生儿重症甲状旁腺功能亢进症(NSHPT)患者中被鉴定出来。我们研究了一个同时表现出FHH和NSHPT的新斯科舍人群体的家庭成员,通过对CaR基因外显子进行PCR扩增,发现FHH个体为杂合子,而NSHPT个体对于异常大的外显子7为纯合子。这是由于在预测变体/人类特异性-1亚家族的一个Alu重复元件的第877密码子处发生了插入。它与CaR基因的方向相反,并且包含一个异常长的聚腺苷酸尾。Alu序列内的所有阅读框中都引入了终止信号,导致预测的突变型CaR蛋白缩短。CaR羧基末端细胞内结构域的大部分缺失将极大地损害其信号转导能力。鉴定该群体中导致FHH/NSHPT表型的特定突变将有助于对高危个体进行快速检测。